Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States
ND Wong, V Lopez, S Tang, GR Williams - The American journal of …, 2006 - Elsevier
Hypertension and hypercholesterolemia are important modifiable risk factors for
cardiovascular disease (CVD). We examined the prevalence, treatment, and control of …
cardiovascular disease (CVD). We examined the prevalence, treatment, and control of …
Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988–2010
BM Egan, J Li, S Qanungo, TE Wolfman - Circulation, 2013 - Am Heart Assoc
Background—Hypertension doubles coronary heart disease (CHD) risk. Treating
hypertension only reduces CHD risk≈ 25%. Treating hypercholesterolemia in hypertensive …
hypertension only reduces CHD risk≈ 25%. Treating hypercholesterolemia in hypertensive …
[PDF][PDF] Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease
ML Johnson, K Pietz, DS Battleman, RJ Beyth - Heart Dis, 2004 - ajmc.s3.amazonaws.com
Prevalence of Comorbid Hypertension and Dyslipidemia and Associated Cardiovascular Disease
Page 1 Cardiovascular disease (CVD) is estimated to affect more than 64 million individuals in …
Page 1 Cardiovascular disease (CVD) is estimated to affect more than 64 million individuals in …
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease
OBJECTIVE: To compare the prevalence of modifiable risk factors for cardiovascular
disease among hypertensive and nonhypertensive adults and to estimate the effect of …
disease among hypertensive and nonhypertensive adults and to estimate the effect of …
A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada
RJ Petrella, E Merikle - Clinical therapeutics, 2008 - Elsevier
Background: Previous evaluations of the Southwestern Ontario (SSWO) cohort have
reported that hypertension (HTN) and dyslipidemia (DYS) are undertreated illnesses; …
reported that hypertension (HTN) and dyslipidemia (DYS) are undertreated illnesses; …
[PDF][PDF] High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population
JV Selby, T Peng, AJ Karter… - … of Managed Care, 2004 - ajmc.s3.amazonaws.com
Objective: To examine prevalence and co-occurrence of diabetes mellitus (DM),
hypertension (HT), and elevated low-density lipoprotein cholesterol (dyslipidemia, or DL) in …
hypertension (HT), and elevated low-density lipoprotein cholesterol (dyslipidemia, or DL) in …
Prevalence and prognostic significance of hypercholesterolemia in men with hypertension: Prospective data on the primary screenees of the Multiple Risk Factor …
J Stamler, D Wentworth, JD Neaton… - The American journal of …, 1986 - Elsevier
To assess the impact of serum cholesterol level on the risk of fatal coronary heart disease for
men with high blood pressure, the six-year follow-up data from 361,662 men (aged 35 to 57 …
men with high blood pressure, the six-year follow-up data from 361,662 men (aged 35 to 57 …
The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease
JB Kostis - Cardiovascular drugs and therapy, 2007 - Springer
Background Clinical management of two key modifiable risk factors for cardiovascular
disease (CVD), hypertension and dyslipidemia, has evolved considerably over the past 40 …
disease (CVD), hypertension and dyslipidemia, has evolved considerably over the past 40 …
Hypertension control and cardiometabolic risk: a regional perspective
M Thoenes, P Bramlage, S Zhong… - Cardiology research …, 2012 - Wiley Online Library
Background. We investigated the association between blood pressure control and common
cardiometabolic risk factors from a global and regional perspective. Methods. In the present …
cardiometabolic risk factors from a global and regional perspective. Methods. In the present …
Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study
A Onat, G Hergenç, I Sarı, S Türkmen… - American journal of …, 2005 - academic.oup.com
Background: The prevalence, features, and risk of cardiovascular disease (CVD) in
dyslipidemic hypertension (DH) was investigated in a prospective population-based study …
dyslipidemic hypertension (DH) was investigated in a prospective population-based study …